|Articles|May 23, 2007

Wyeth CFO and VC to Leave the Company

Author(s)BioPharm International Editors

Kenneth J. Martin, Wyeth's (Madison, NJ, www.wyeth.com) chief financial officer and vice chairman, has announced plans to leave the company at the end of June.

Kenneth J. Martin, Wyeth’s (Madison, NJ, www.wyeth.com) chief financial officer and vice chairman, has announced plans to leave the company at the end of June. Martin joined the Wyeth in 1984 and has served as the CFO since 2000. The company plans to name a new CFO in advance of Martin’s departure.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Wyeth CFO and VC to Leave the Company

Newsletter

Related Content

How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships

RNAnalytics Goes Beyond Nanoparticle Analysis at CPHI Frankfurt

Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization

BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints

BioPharm Weekly News Roundup—Week of Oct. 27, 2025

Trending on BioPharm International

Meeting Global Demand and Delivering Faster, More Reliable Service

A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities

How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships

Managing Risk and Minimizing the Complexity of Your Global Single-Use Supply Chain

Streamlining Procurement and Inventory Management Leads to Increased Productivity